Journal of the European Academy of Dermatology and Venereology

Article	Citations
Issue Information	303
Announcement	200
Editor's Picks January 2024	192
Announcement	164
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	164
	152
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	130
Peer review, scientific publishing and the law of reciprocity	103
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	93
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	87
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	85
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	80
Announcement	76
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024	72
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	72
Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach	70
Efficacy of imiquimod in the management of lentigo maligna	69
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	67
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	61
Two cases of cerebrovascular accidents following the induction dose of risankizumab	59
Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination	57
Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial	55
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	52
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	52
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort	52

Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	49
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	49
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment	45
Are non‐fungible tokens the barrier to realizing the Dermoverse?	45
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	45
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US	45
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	44
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination	44
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study	43
Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’	43
Advances in biologic therapy of psoriasis	43
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	43
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	43
Urinary incontinence and female genital lichen sclerosus	42
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	41
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	41
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	41
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	41
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	41
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	40
Can we trust AI for acne advice: A double‐blind performance comparison with NICE guidelines	40
Biomarkers in rosacea: A systematic review	40
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	39
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	39
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	39
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	38
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	38
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine	38
A new era for alopecia areata: New treatments and improved knowledge of the condition	38
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	38
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	38
Impact of menopause on the skin…information still insufficient	37
Issue Information	36
	36
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	35
	35
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	35
Announcement	35
Announcement	35
Louis Adolphus Duhring: An enduring legacy	34
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	34
Juvenile localized scleroderma: A single‐centre experience from India	34
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	34
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	33
Dalbavancin for the treatment of severe hidradenitis suppurativa	33
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	33
Pharmacovigilance: The responsibility of all	33
A case of eruptive halo nevi following COVID‐19	33
The future of digital pills and their potential use in dermatological clinical trials	33
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–2019	33

The chicken or the egg of lymphopenia in atopic eczema	33
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	32
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	32
Delphi consensus on melasma management by international experts and pigmentary disorders society	31
Editor’s Picks June 2025	31
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	31
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis	31
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	31
Chat GPT in dermatology: Progressive or problematic?	31
Educational, labour market and relationship outcomes in people with acne	31
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	30
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	30
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	30
Application of integrated skincare in medical aesthetics: A literature review	30
Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis	30
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	30
Microinfusion of 5‐fluorouracil using a tattooing machine in keloid treatment	30
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	30
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	29
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	29
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	29
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	29
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	29
	28
Announcement	28
Commentary to ‘Development of a patient‐reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.	28
Issue Information	28
Announcement	28
	28
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	28
	27
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	27
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	27
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	27
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	27
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	27
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	26
Morphoea en coup de sabre with Adie's pupil: An exceptional association	26
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	26
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	26
Drug reaction with eosinophilia and systemic symptoms in a 10‐year‐old boy sparing lichen planus lesions: an example of reverse isotopic response	26
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	26
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	26
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	26
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	25
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	25
Timing, age and immune profiling refine strategy in lichenoid chronic GVHD – Authors' reply	25
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	25
Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	25
Severity strata and minimally important differences of CompAQ and Skindex‐16 for patients with acne	25
Deciphering differential response to NB‐UVB: The hair matters	25
Modest psoriasis risk from cardiometabolic progression: Genetics, patterns and limitations in a Biobank study	24
Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.	24
	24
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	24
Chronic pruritus in multiple sclerosis and clinical correlates	24
Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics	24
Announcement	24
A special thank you to our reviewers!	24
Erectile dysfunction in patients with seborrhoeic dermatitis	24
Announcement	24
Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients	23
Beta‐blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review	23
	23
Stevens‐Johnson syndrome induced by Vaxvetria (AZD1222) COVID‐19 vaccine	23
Sensitivity of clinician‐assessed efficacy outcome measurement instruments in trials of topical therapies for atopic dermatitis: a systematic review and meta‐analysis	23
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	23
	23
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	23
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	23
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	23
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	23
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction	23
Dermatitis herpetiformis triggered by iodine contrast media	23
Scabies revisited in the COVID‐19 era	23
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	22
Incidence and remission rates of self‐reported hidradenitis suppurativa ‐ A prospective cohort study conducted in Danish blood donors	22
Beyond the surface: Integrating sex and gender in dermatologic therapy	22
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	22
Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies	22

Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	22
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	22
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	22
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	22
Paediatric mycosis fungoides – characteristics, management and outcomes with particular focus on the folliculotropic variant	22
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	22
Is risankizumab as needed administration a good option for patients with plaque psoriasis?	22
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	21
New regulation of medical devices in the EU: impact in dermatology	21
2021 European guideline on the management of Mycoplasma genitalium infections	21
Response to Letter to the Editor—Assessing UWB‐RSOM for non‐invasive melanoma depth: Diagnostic potential and critical limitations	21
Burnout among French dermatologists: A national study	21
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	21
Scratching the surface: NK‐1 inhibitors for chronic itch—Promise or placebo?	21
AI‐assisted basal cell carcinoma diagnosis with LC‐OCT: A multicentric retrospective study	21
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	21
Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics	21
Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients	21
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	21
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients	20
From COVID‐19 to war – life of a dermatological journal in times of crisis	20
The watch sign: an atypical clinical finding of frontal fibrosing alopecia in two male patients	20
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	20
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study	20
Announcement	20
Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study	20
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	20
Alopecia universalis improvement following risankizumab in a psoriasis patient	20
Delayed hypersensitivity of hyaluronidase: a case report	20
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	20
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	20
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide‐scale cohort study	20
False negative RPR test with prozone phenomenon in an HIV‐negative man with secondary syphilis	20
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	19
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	19
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	19
Nonsense mutations in KRT1 caused recessive epidermolytic palmoplantar keratoderma with knuckle pads	19
Neuropathy as an early warning sign of desmoplastic neurotropic melanoma of the head	19
Thirty years of promoting sun safety in France: The messages are heard but not followed!	19
Racial representation in dermatology clinical trials, a Canadian perspective	19
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	19
Store‐and‐forward mobile application as an accessible method of study participant assessment	19
Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience	19
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials	19
Improvement of redness and hyperkeratosis in a case of Nagashima‐type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis	19
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	19
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	19
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	19
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	19
Non‐invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM‐OCT imaging device: a case‐series	19
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	19
Issue Information	19
Culture‐based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients	19
Concordance of in vivo reflectance confocal microscopy and horizontal‐sectioning histology in skin tumours	19
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	19
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	19
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	18
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	18
Beremagene geperpavec (B‐VEC) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention	18
Premature skin ageing signs due to androgen deprivation therapy	18
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	18
Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’	18
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients	18
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	18
Trichophyton mentagrophytesITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon	18
Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning	18
Granular parakeratosis	18
Advances in image‐based diagnosis of nail disorders	18
Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up	18
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study	18
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	18
The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico‐histopathologic presentation	17
Hidradenitis suppurativa: A prospective epidemiologic study in Albania	17
Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain‐of‐function mutation	17
Lentigo maligna: A retrospective analysis of 50 cases treated with imiquimod monitored with non‐invasive reflectance confocal microscopy	17
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry	17
Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angio	17
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	17
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study	17
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature	17
Announcement	17
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	17
Probing into functional decline among bullous pemphigoid patients	17
A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections	17
Wound healing and microbiome, an unexpected relationship	17
Sensitive skin: A relevant syndrome, be aware	17
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb ran	17
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	17
Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study	17
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	17
Merkel cell carcinoma after solid organ transplant	17
	17
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors	17
Rapid and sustained improvement of cutaneous lichen planus with oral JAK1 inhibitors	16
Forthcoming EADV Events	16